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Abstract
Cystic fibrosis (CF) is the most common lethal autosomal recessive disease in the Caucasian population. It is due to
mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. To date, over 1910 mutations have
been identified in the CFTR gene. Among these mutations, the CF-causing missense mutation G551D-CFTR (approx. 5% of
cases) encodes for a CFTR chloride channel with normal expression on the cell surface. Nevertheless, it is associated with
severe disease due to its altered channel activation. The aim of the present study was to identify specific interacting proteins
of G551D-CFTR. Co-immunoprecipitated proteins with G551D-CFTR were resolved by 2D-gel electrophoresis (2-DE). Mass
Spectrometry revealed that calumenin was present in the protein complex linked to G551D-CFTR. Despite its basal
expression was not modified in G551D-CFTR expressing cells when compared to Wt-CFTR expressing cells, it was more
abundant in the G551D-CFTR complex detected by immunoprecipitation. The calumenin-CFTR interaction was also shown
by Surface Plasmon Resonance and further confirmed by computational analysis of the predicted calumenin’s partners.
Because in our cellular model calumenin was found in the endoplasmic reticulum (ER) by immunofluorescence experiments,
we suggest that calumenin is likely involved in the mutated CFTR’s maturation. In conclusion, we showed for the first time
that calumenin binds to CFTR and that it is increased in the G551D-CFTR complex. We suggest that it may be involved in the
physiopathology of G551D-CFTR and that G551D-CFTR may follow a specific maturation and trafficking pathway. We also
hypothesize that UPR may be triggered independently of the retention of G551D-CFTR in the ER because Grp78/Bip
expression is increased in the cells. Finally, we propose here that Calumenin is a new CFTR chaperone.
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Introduction
Cystic fibrosis (CF) is the most common lethal autosomal
recessive disease in the Caucasian population. It is due to
mutations in the cystic fibrosis transmembrane conductance
regulator (CFTR) gene [1–3]. CFTR is an ATP-binding cassette
transporter functions as a chloride (Cl
-) channel [4–6] and
comprises two hydrophobic core regions, two nucleotide-binding
domains (NBDs) with ATP-binding activity [7] and a regulatory
domain (R domain). CFTR channel opening requires phosphor-
ylation by cAMP-dependent protein kinases (PKA) [8] and
hydrolyzable MgATP [9,10]. Both genetic and interacting proteins
seem to be involved in the CFTR regulation. Indeed, CFTR
regulation is complex and involves dimerization of the protein
[11,12] and interdomain interactions [13]. Syntaxin 1A, EBP50,
E3KARP, the m subunit of the endocytic clathrin adaptor
complex, cysteine string proteins and annexin A5 are CFTR-
binding proteins [14–19], but the extent to which CFTR channels
are regulated by protein-protein interactions remains largely
unknown.
To date, over 1910 mutations (www.genet.sickkids.on.ca/cftr/)
have been identified in the CFTR gene and a classification of
mutations by which different mechanisms induce CF has been
proposed [20]. Among these mutations, the CF-causing missense
mutation G551D-CFTR (Gly to Asp at position 551) exhibits
normal expression at the cell surface but it is associated with severe
disease [21,22]. Indeed, it lacks channel activation mediated by
ATP [23,24]. G551D-CFTR is not a common mutation in the CF
patients (approx. 5% of cases) but the clinical phenotype is
considered very severe. Therefore, efforts have been taken to
overcome the G551D-CFTR defect. Biochemical studies on
purified and reconstituted G551D-CFTR showed the potentiation
of the ATPase activity by VRT-532 [25]. Nevertheless, VRT-532
did not affect the ATPase activity of the Wt (wild-type) CFTR.
This supported the idea that this compound corrects the specific
molecular defect of this mutant by a direct or indirect binding,
stabilizing an intramolecular interaction. This potentiator seems to
have a mutant specificity which may be due to CFTR interacting
proteins [26].
As it is suggested that G551D-CFTR has different binding
partners when compared to Wt-CFTR, the aim of the present
study was to identify specific interacting proteins of G551D-
CFTR. The proteins linked to G551D-CFTR were resolved by
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exhibited a high intensity and was subjected to Mass Spectrometry
(MS). MS revealed that the corresponding protein was calumenin.
We found that its basal expression was not modified in G551D-
CFTR expressing cells when compared to Wt-CFTR expressing
cells. Using co-immunoprecipitation, we found that calumenin was
bound to the G551D-CFTR protein. The co-immunoprecipitation
experiment also indicated that calumenin was also bound to Wt-
CFTR. Nevertheless, the amount of bound calumenin was higher
in the G551D-CFTR complex than in the Wt-CFTR one. The
calumenin - CFTR interaction was further confirmed by
computational interaction prediction and by Surface Plasmon
Resonance (SPR). In order to know whether calumenin was
localized in the Endoplasmic Reticulum (ER) in our cell model
and whether the interaction takes place in the ER in which
calumenin is known to be present, immunofluorescence was
performed. We found that the calumenin - CFTR interaction is
indeed only present in the ER of the cells. Because calumenin
expression is modulated in cells expressing the most frequent
CFTR mutant (F508del) together with Grp78/Bip which is
a hallmark of the Unfolded Protein Response (UPR) and because
we found an increased level of calumenin linked to G551D-CFTR,
we assessed the Grp78 expression in the cells. We found that
Grp78 expression was increased in G551D-CFTR expressing cells,
suggesting that calumenin is likely involved in the maturation of
CFTR within the ER, that G551D-CFTR may follow a specific
maturation and trafficking pathway and that UPR may be
triggered in CF independently of the retention of G551D-CFTR
in the ER. Finally, we propose that Calumenin is a new CFTR’s
chaperone.
Results and Discussion
Wt-CFTR and G551D-CFTR were expressed in Hela cells
which do not endogenously express CFTR and their function was
measured by [27,28]. The expression of the CFTR protein was
assessed by western blotting. As shown in Fig. 1A the mature fully
glycosylated CFTR and core-glycosylated CFTR were expressed
in both cell types. Therefore, we found that in our cell model the
mutant protein can fold and traffic normally to the plasma
membrane. This was in accordance with previous results showing
that G551D-CFTR exhibits no trafficking defects [23,29]. We
investigated the cAMP-dependent halide flux through Wt-CFTR
and G551D-CFTR (Fig. 1B) in the stably transfected cells. We
found that it was deeply decreased in G551D-CFTR cells, as
previously described [9,29]. Therefore, we showed that viral
tranfection of the cells led to the expression of Wt-CFTR and
G551D-CFTR and that their expression and function were in
accordance with previous results, indicating that the cell model
could be used for further experiments.
A reference 2-DE (pH 4–7) of 6 gels performed with proteins
complex linked to G551D-CFTR obtained by immunoprecipita-
tion is presented in Fig. 2A. The image data analysis detected 165
protein spots in the complex. The spot showing the higher
expression was further analyzed (A, on Fig. 2A). It was excised
from the gel, trypsined and analyzed by MS. The results indicate
that the spot corresponded to calumenin (table 1). The MS/MS
results leading to calumenin identification are summarized in
table 2. The MS spectrum and the coverage of the calumenin
sequence are presented in Fig. 2B.
Calumenin is a multiple EF-hand Ca
2+-binding protein located
in the ER. It belongs to the CREC family of Ca
2+-binding
proteins. It is also found in the secretory pathway and can be
secreted to the extracellular space. It interacts with different
ligands and it inhibits several proteins in the ER membrane such
as the ryanodine receptor (RyR2) and the Ca
2+-transporting
ATPase (SERCA2). Some other functions concern participation in
the secretory process, ER lumenal chaperone activity and signal
transduction. It is also involved in a large variety of disease
processes (for review [30]) and it was shown to be involved in the
Ca
2+ homeostasis of the ER, due to a direct interaction with
SERCA2 and RyR2. Indeed, an inhibition of SERCA2-mediated
Ca
2+ uptake into SR in cardiomyocyte due to an interaction with
calumenin was observed [31]. To assess the expression of
calumenin in G551D-CFTR expressing cells, western blots
(n=5) were performed to compare its basal level with that of
wt-CFTR expressing cells. As shown in Fig. 3A, no difference was
observed between Wt- or G551D-CFTR expressing cells suggest-
ing that it is not involved in a difference of the Ca
2+ homeostasis
between Wt- and G551D-CFTR cells. Whereas, calumenin was
detected in the CFTR’s ER-Associated Folding Proteome and
seems to be modulated in Fdel508-CFTR expressing cells, its
direct interaction with CFTR has never clearly been established
[32,33]. Therefore, we assessed its interaction with CFTR by
coimmunoprecipitation. As shown in Fig. 3B, we found that
calumenin was bound to CFTR and that it was more abundant in
the G551D-CFTR complex than in the Wt-CFTR complex. The
reverse coimmunoprecipitation indicated that the amount of
bound G551D-CFTR onto calumenin was higher than the
amount of bound Wt-CFTR (not shown). Because we found that
calumenin binds to the mature G551D-CFTR form (170 kDa) and
because human calumenin is found in the ER as well as in the
Golgi complex [34], our results suggest that it is likely involved in
the CFTR maturation.
Grp78/Bip is a major sensor for the Unfolded Protein Response
(UPR) triggering in the ER. It is modulated as well as calumenin in
F508del-CFTR expressing cells and we previously showed that it is
involved in the observed UPR in CF cells [33,35]. Therefore, we
assessed Grp78 expression in G551D-CFTR expressing cells,
using Fdel508-CFTR cells as a positive control. As shown in
Fig. 4A, we observed an increased Grp78 expression in G551D-
CFTR cells when compared to Wt-CFTR expressing cells. The
quantitation indicated that its expression was not significantly
different to that observed in Fdel508-CFTR cells, suggesting the
UPR triggering (Fig. 4B). Because it was previously shown that
G551D-CFTR is not retained in the ER [36] this result suggests
that UPR, or at least an ER stress, may be triggered in G551D-
CFTR expressing cells due to another mechanism involving
calumenin.
Because the calumenin - CFTR interaction in the ER of cells
had never been shown before and because some extra bands were
observed when calumenin was detected in the cells using western
blottings, we had to further provide evidence showing this
interaction. For this purpose, Surface Plasmon Resonance was
used [37]. The sensorgrams obtained when pure calumenin was
linked on a sensorchip and pure CFTR was injected (0.15 to
1.5 nM), showing an interaction followed by a dissociation phase
which was not zero when the injection was stopped indicated that
the interaction occured (Fig. 5A). The obtained value for the
dissociation constant was 3.8610
212 M showing a strong in-
teraction. The opposite experiment in which purified CFTR was
linked on the sensorchip was also performed (not shown). The SPR
experiments confirming the direct interaction permitted to rule out
the possibility of an unspecific binding during co-immunoprecip-
itation experiments. The calumenin - CFTR interaction was also
evaluated with the online Search Tool for the Retrieval of
Interacting Genes/Protein (STRING 9.0, http://string-db.org) to
predict both direct and indirect interactions [38]. As shown in
Calumenin and G551D - CFTR Association
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predicted calumenin’s partners which are listed in Table 3, some
are depicted and characterized by biochemical experiments such
as RyR and ATP2A2 [30,31]. In order to show that in our cell
model calumenin is located within the ER, as described in other
cell types, immunofluorescence was performed. The nuclei of the
cells as well as the ER and calumenin were labelled in wt- and
G551D-CFTR expressing cells (Fig. 6). The results indicated that
in our cell model calumenin is indeed localized in the ER and that
therefore the described interaction between Calumenin and wt- or
G551D-CFTR takes place within the ER.
Conclusion
Our results suggest that the G551D-CFTR’s maturation/
trafficking is different from the one of Wt-CFTR because it likely
involves more calumenin. Furthermore, we suggest that UPR is
likely triggered in G551D-CFTR expressing cells. Nevertheless,
the UPR pathway may be different than the one observed in
Fdel508-CFTR cells because the G551D-CFTR protein is not
retained in the ER. In conclusion, we show here a direct
calumenin - wt-CFTR and calumenin - G551D-CFTR interac-
tion. Because we found the interaction within the ER and because
the amount of bound calumenin is likely higher with the mutated
CFTR, we propose that the G551D-CFTR protein may be
directed to a specific trafficking pathway. The exact role of
calumenin upon UPR in G551D-CFTR expressing cells is now
under investigation in our laboratory as well as its possible role as
a chaperone for the most frequent mutation found in CF (F508del)
which is retained in the ER. Furthermore, according to the Bip/
Grp78 expression, we propose that UPR may be triggered in
G551D-CFTR expressing cells, independently of any retention of
the mutated CFTR in the ER.
Materials and Methods
Plasmid Construction
The pLenti6/V5-CFTR mammalian expression lentiviral con-
struct, driven by the cytomegalovirus promoter was constructed
using ViraPower
TM Lentiviral Directional TOPOH Expression Kit
(Invitrogen). To clone the cDNA encoding the human wild type
CFTR (Wt-CFTR, Transgene SA, pTG5985, France, access
Genbank no. M28668) into the pLenti vector, a forward primer
sequence with 4 nucleotides CACC- at the 59 end, based on the
TOPO-cloning technology, was designed according to manufac-
turer’s instruction. The cDNAs encoding G551D-CFTR and
F508del-CFTR were generated by site-directed mutagenesis
(QuickChange II XL Site-Directed Mutagenesis Kit, Stratagene).
Viral Particle Production and Cell Transfection
6x10
6 293FT cells (provided with the ViraPower
TM Lentiviral
Directional TOPOH Expression Kit, InVitrogen) were plated 24
hours prior to the addition of a complex comprising Wt-CFTR,
G551D-CFTR or F508del-CFTR plasmid and Lipofectamine
TM
2000 (Invitrogen). The HIV type 1 (HIV-1) gag-pol construct pLP1,
rev construct pLP2 and the Vesicular Stomatitis Virus G
glycoprotein (VSV-G) construct pLP/VSVG were delivered
together with the pLenti expression vector into the cells at a ratio
of 3:3:3:3 mg, respectively. Cells were washed 24 hours post-
transfection and incubated with fresh media. Supernatants
containing viral particles were harvested 72 hours post-transfection
and titrated on HeLa cells. The remaining virus was stored at
280uC before use. The transfection of HeLa cells was performed
in the presence of Polybrene (6 mg/ml, Chemicon). To transfect
2610
5 cells, 1 mL supernatants containing lentivirus was added
(3610
3 TU/ml). Cells were incubated with fresh media 24 hours
after transfection and were subsequently treated by Blasticitin for
antibiotic selection 48 hours after transfection.
Cell Culture
293FT cells and HeLa cells (from ATCC, NuCRM-CCL-2,
USA) were cultured in Dulbecco’s Modified Eagle’s medium
supplemented with 10% fetal bovine serum. HeLa cells stably
expressing either Wt-CFTR, G551D-CFTR and F508del-CFTR
were selected using Blasticitin (2 mg/ml) for at least 10 days.
Protein Preparation and Immunoblot Analysis
Wt-CFTR, G551D-CFTR and F508del-CFTR expressing cells
were collected and homogenized using a glass homogenizer in
2 mL of RIPA buffer. Lyzates were ultra-centrifuged (32500 rpm,
30 min., 4uC). The pellets were resuspended in 500 mL of RIPA.
The Wt-CFTR, G551D-CFTR and F508del-CFTR expression
were assessed by western blottings. Proteins (50 mg) were loaded
on a Bis/Tris precasted polyacrylamide gel (10%, Invitrogen) and
transferred onto a PVDF membrane. CFTR proteins were probed
using a monoclonal anti-CFTR antibody (24-1, R&D System) and
a horseradish peroxidase (HRP) conjugated secondary antibody
(Amersham). Other used antibodies were polyclonal anti-calum-
enin antibody (D-19, Santa Cruz Biotechnology) and polyclonal
Figure 1. Validation of the cell model. A, Wt-CFTR and G551D-CFTR expression in Hela cells. Example of western blot showing the mature fully
glycosylated CFTR and core-glycosylated CFTR labeled as Band C (170 kDa) and Band B, respectively. B, Study of the cyclic AMP-induced I
2 efflux
from Wt-CFTR (n=3) and G551D-CFTR (n=3) using SPQ experiments. The halide permeability (p) is the rate of SPQ dequenching. The graphs show
a deeply decreased activity in G551D-CFTR expressing cells. Data are the means 6 S.E.M., ***: p,0.001.
doi:10.1371/journal.pone.0040173.g001
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radish peroxidase (HRP) conjugated secondary antibodies were
from Amersham. Blots were developed by enhanced chemilumi-
nescence kit (ECL Plus, Amersham) and analyzed using Chemi-
Smart 5100 ECL imaging system (Vilber Lourmat). Intensity of
each band was quantified using densitometric analysis of the
signals (GelDoc 2000, Biorad). Each value was normalized by the
total amount of the loaded proteins per lane which was estimated
Figure 2. Calumenin belongs to the G551D-CFTR’s complex. A, Example of a reference 2-DE (pH 4–7) of 6 gels performed with
immunoprecipitated G551D-CFTR. The image analysis detected 165 protein spots. The analyzed spot is noted as A. B, MS spectra obtained for the A
spot and protein coverage (24%) shown in bold red on the calumenin amino acid sequence (gi/2809324).
doi:10.1371/journal.pone.0040173.g002
Table 1. Identification of spots A by Mass Spectrometry.









A NM001219 Calumenin CALU (Homo
sapiens)
67 66 37084/4.47 G551D-CFTR
doi:10.1371/journal.pone.0040173.t001
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was also performed by the actin signal obtained on the same
membranes. The results did not vary with the normalization type.
Methoxy-N-(3-sulfopropyl)quinolinium (SPQ)
Fluorescence Assay
Stably transfected cells expressing either Wt-CFTR or G551D-
CFTR were used in SPQ experiments as previously described,
using forskolin as CFTR activator because it induces cAMP
synthesis which regulates the CFTR chloride channel function
[19,27]. Cells were loaded with intracellular SPQ dye by
incubation in Ca
2+ -free hypotonic (50% dilution) medium
containing 10 mM SPQ, 15 min, at 37uC. Coverslips were
mounted on the stage of an inverted microscope equipped for
fluorescence and illuminated at 360 nm. The emitted light was
collected at 456+/233 nm by a high-resolution image intensifier
coupled to a video camera connected to a digital image
processing board controlled by FLUO software (Imstar, France).
Cells were maintained at 37uC and continuously superfused with
an extracellular solution containing in mM:145 NaCl, 4 KCl,
1 MgCl2, 1 CaCl2, 5 HEPES and 5 glucose, pH 7.4. A
microperfusion system allowed local application and rapid
change of the different experimental mediums. Iodide (I
2) and
nitrate (NO3
2) containing media were identical to the extracel-




dominant extracellular anions. All extracellular media also
contained 10 mM bumetanide to inhibit the Cl
2/Na+/K+ co-
transporter. Single-cell fluorescence intensity was measured from
digital image processing and displayed against time. Fluorescence
intensity was standardized according to the equation F=(F2Fo)/
Fo6100, where F is the relative fluorescence and Fo, the
fluorescence intensity measured in presence of I
-. The halides
membrane permeability (p) was determined as the rate of SPQ
dequenching upon perfusion with nitrates. At least three
successive data points were collected immediately after the
NO3
2 containing medium application, and then fitted using
a linear regression analysis. The slope of the straight line
reflecting the membrane permeability to halides (noted p in min-
1) was used as an index of CFTR activity [19,27].
Immunoprecipitation
Stably transfected HeLa cells expressing G551D-CFTR were
washed in cold PBS, scraped into PBS, pelleted and resuspended
in the RIPA buffer (25 mM Tris-HCl, 150 mM NaCl, 1%
Triton X-100, 1% Na deoxycholate, 0.1% SDS, 10 mM
iodoacetamide, 100 mM PMSF, pH 7.5) in the presence of fresh
protease inhibitor cocktail (P8340, Sigma-Aldrich) at a final
concentration of 4.5 ml/ml. Anti-CFTR monoclonal antibody
M3A7 (Millipore) or anti-calumenin antibody was incubated with
magnetic beads (Dyna beats Protein G, Invitrogen) at a final
concentration of 0.2 mg per ml of wet beads at 4uC for 1 hour
with rocking. 500 mg of whole cell lysate were applied to the
beads-antibody complex. Beads were then incubated at 4uC
overnight and washed 3 times in cold PBS. Immunoprecipitated
Table 2. MS/MS results for Calumenin identification.
Tree hierarchy Meas. M/z Calc. MH+ Meas. Mr Calc. Mr Int. Dev.(ppm) Score
Mascot
Score Range
MSMS 25 1887,858 1887,851 1886,851 1886,843 18320,6 3,746 25 81 256–271
MSMS 38 2064,898 2064,89 2063,891 2063,882 3936,262 4,134 7 7 174–189
MSMS 50 2479,115 2479,08 2478,108 2478,072 11680,34 14,325 89 109 38–59
MSMS 55 2701,385 2701,336 2700,378 2700,328 8222,202 18,254 2059 152 288–311
Search Parameter: Charge=1+, Trypsin, Mascot 2.3.01.241, NCBInr NCBInr_20120204.fasta; Modifications: Global: Carboxymethyl (C), Optional: Oxidation (M). Individual ions
scores .51 indicate identity or extensive homology (p,0.05). Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits.
doi:10.1371/journal.pone.0040173.t002
Figure 3. More calumenin is bound onto G551D-CFTR than onto Wt-CFTR. A, Example of detection of calumenin in Wt-CFTR and G551D
expressing cells, assessed by western blotting using whole cell lysates. No difference was observed between the two cell lines. Pure Calumenin was
loaded as a molecular weight control because of the presence of non-specific bands on the membrane. B, Example of coimmunoprecipitation
showing the calumenin-CFTR interaction in total proteins (left). Histogram represents the quantitation indicating that more calumenin is bound onto
G551D-CFTR than onto Wt-CFTR (right).
doi:10.1371/journal.pone.0040173.g003
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loading buffer at 95uC for 10 min. Control experiments were
performed without any antibody linked to the beads.
Immunofluorescence
Cells were fixed in 4% PFA for 10 min. After fixation and three
5-min washes with PBS-T (PBS 1X plus Tween 0.1%), cells were
permeabilized with 0.5% Triton X-100 in PBS for 4 min. After 5-
min washes with PBS-T, nonspecific binding was prevented by
blocking with 2% BSA in PBS 1X f (30 min, room temperature
(RT)). Primary antibody against Calu (H-40, Santa Cruz; 1:100 in
BSA 2%) was applied for 2 h at RT. After three 5-min washes with
PBS-T, cells were incubated for 1 h 30 at RT with Alexa fluor 488
goat anti-rabbit IgG (Molecular probes) secondary antibody
diluted 1:1000 in BSA 2%. Then, after three 5-min washes with
PBS-T, a second labelling against PDI (Protein Disulfide
Isomerase, Invitrogen) was performed. Primary antibody against
PDI (1:1000 in 2% BSA) was applied (12 h, 4uC). After three 5-
min washes with PBS-T, cells were incubated for 1 h 30 at RT
with Goat anti mouse texas red (Molecular probes) secondary
antibody diluted (1:1000 in BSA 2%). Nuclei were labelled with
DAPI (Sigma; 1:1000 in PBS 1X). Slides were mounted with
Fluorsave (Calbiochem) and examined under a Zeiss AxioStar-
Plus microscope. Images were collected with Zeiss 1006
objectives.
Two-dimensional Gel Electrophoresis (2-DE)
To perform isoelectric focusing, proteins (100 micrograms) were
diluted in rehydration buffer (6 M urea, 2 M thiourea, 4%
CHAPS, 0.02 M DTT, 0.5% IPG Buffer) to obtain a 125 mL final
volume. Samples were loaded onto 7 cm linear pH 4–7 strips
(Immoboline DryStrip, GE Healthcare). An Ettan IPGphor
Isoelectric Focusing system (GE Healthcare) was used for the first
dimension. The second dimension (10% NuPage Bis/Tris precast
acrylamide gel) was performed on XCell SureLockH Mini-Cell
system (Invitrogen). Coomassie Blue staining was used for image
analysis and MS experiments.
Image Acquisition and 2-D Gel Analysis
Coomassie Blue 2-DE gels were scanned and digitized using the
GS-800 Calibrated Densitometer (Bio-Rad). Gel alignment, spot
detection and quantification were performed using the PDQuest
software (Sensitivity: 31.70, Size scale: 3, Min peak: 160, Bio-Rad).
Data are the means of six gels from six different experiments.
Mass Spectrometry
Maldi-TOF/TOF analysis of protein spot was performed. The
target protein spot was excised from the stained gels, destained and
denatured. The gel-piece was then incubated in digestion solution
containing 20 mg/mL proteomics grade trypsin for 10–12 h at
37uC. The products of tryptic digestion were deposited on PAC
(Prespotted AnchorChip) from Bruker Daltonics. The tryptic
peptides were analysed using an autoflex III MALDI-TOF TOF
equipped with a smartbeam laser and controlled by the
FlexControl 3.0 and FlexAnalysis 3.0 software package. The mass
spectrometer was operated with positive polarity in reflectron
mode and spectra acquired in the range of m/z 500–4000. A
timed ion gate was used for precursor ion selection and the
fragments generated were further accelerated with 21 kV in the
LIFT cell, and detected following passage through the reflectron.
The used software was BioTools 3.2 (Bruker Daltonics). MS
spectrum was performed in data-depended mode in which up to 4
precursor ions above an intensity threshold of 7 counts/s (cps)
were selected for MS analysis from each survey ‘‘scan’’. The
tandem mass spectrometry data was converted into a PKL file
using Masslynx v 4.0 software (Micromass, Waters, USA) and then
was imported into a local Mascot 3.2 search engine. The search
parameters in MatrixScience Mascot were as follows: the enzyme
was trypsin; the taxonomy was selected as Homo sapiens; the mass
tolerance was 60.3 Da; the MS/MS tolerance was 60.5 Da; the
missed cleavage sites were allowed up to 1; the fixed modifications
in NCBI nr were selected as carboxymethyl (cysteine); the variable
modification was selected as oxidation (methylation) or none; the
data format was selected as micromass PKL format; and the
instrument was selected as MALDI-TOF/TOF. Individual ions
Figure 4. UPR is likely triggered in G551D-CFTR expressing cells. A, Example of detection of Grp78 in Wt-CFTR, Fdel508-CFTR and G551D-
CFTR expressing cells, assessed by western blotting using whole cell lysates. A Fdel508-CFTR expressing cell lysate was used as a positive control. B,
Histogram represents the quantitation indicating that the amount of Grp78 is increased in Fdel508-CFTR and G551D-CFTR expressing cells whereas
no difference is observed between Fdel508-CFTR and G551D-CFTR expressing cells (right).
doi:10.1371/journal.pone.0040173.g004
Calumenin and G551D - CFTR Association
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e40173Calumenin and G551D - CFTR Association
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e40173scores .51 indicate identity or extensive homology (P,0.05). MS
tolerance was 70 ppm.
Surface Plasmon Resonance
Pure recombinant human calumenin was obtained from
Prospec (Israel) and purified full length CFTR was a generous
gift from Pr Robert Ford (University of Manchester, UK). CM5
Sensor chip, amine coupling kit (N-hydroxysuccinimide, (NHS), N-
ethyl-N-(3-diethylaminopropyl) carbodiimide hydrochloride
(EDC), ethanolamine (1 M, pH 8.5) and HBS-EP buffer
(10 mM HEPES, 150 mM NaCl, 3 mM EDTA, and 0.005%
surfactant P20 at pH 7.4) were obtained from GE Healthcare Bio-
Sciences AB. The experiments were performed at the PurIProb
core facility (Inserm, UMR1078, Brest). Real-time detection of the
Calu - Wt-CFTR were performed using a Biacore system (Biacore
3000; GE Healthcare) and its Control Software version 3.2. All
injections were performed at 25uC in HBS-EP 16running buffer
(GE Healthcare). Biacore 3000 was set at 25uC for all steps during
the analytical process, and experimental data were collected at
Figure 5. Evidence of the direct calumenin-CFTR interaction. A, Example of sensorgrams obtained when pure Calumenin was linked on the
sensorchip and pure CFTR was injected (0.15 to 1.5 nM), showing an interaction followed by a dissociation phase which was not zero when the
injection was stopped. The obtained value for the dissociation constant was 3.8e212 M showing a strong interaction. SPR was performed to rule out
a possible non specific binding in co-immunoprecipitation experiment. B, Network of the predicted interactions for Calumenin obtained by STRING.
Green connecting lines indicates that the interaction in mentioned in PubMed abstracts with no or insignificant experimental data. Pink connecting
lines indicates that the interaction has been demonstrated with available biochemical data. A pink line was observed for the Calumenin - CFTR
interaction [32]. Partners are depicted in Table 3.
doi:10.1371/journal.pone.0040173.g005






AURKA ENSP00000216911, Homo sapiens May play a role in cell cycle regulation during anaphase and/or telophase,
in relation to the function of the centrosome/spindle pole region during
chromosome segregation. May be involved in microtubule formation
and/or stabilization.
0.974
APCS ENSP00000255040, Homo sapiens Amyloid P component, serum. Can interact with DNA and histones and may
scavenge nuclear material released from damaged circulating cells. May also
function as a calcium-dependent lectin
0.929
ATP2A2 ENSP00000324892, Homo sapiens ATPase, Ca
2+ transporting, cardiac muscle, slow twitch 2. This magnesium-
dependent enzyme catalyzes the hydrolysis of ATP coupled with the
translocation of calcium from the cytosol to the sarcoplasmic reticulum
lumen. Isoform SERCA2A is involved in the regulation of the
contraction/relaxation cycle
0.860
RYR2 ENSP00000355533, Homo sapiens ryanodine receptor 2 (cardiac); Communication between transverse-tubules
and sarcoplasmic reticulum. Contraction of cardiac muscle is triggered by
release of calcium ions from SR following depolarization of T- tubules
(By similarity)
0.853
RYR1 ENSP00000352608, Homo sapiens ryanodine receptor 1 (skeletal); Communication between transverse-tubules
and sarcoplasmic reticulum. Contraction of skeletal muscle is triggered by
release of calcium ions from SR following depolarization of T-tubules
0.815
CFTR ENSP00000003084, Homo sapiens cystic fibrosis transmembrane conductance regulator (ATP-binding cassette
sub-family C, member 7); Involved in the transport of chloride ions. May
regulate bicarbonate secretion and salvage in epithelial cells by regulating
the SLC4A7 transporter
0.801
VKORC1 ENSP00000378426, Homo sapiens vitamin K epoxide reductase complex, subunit 1; Involved in vitamin K
metabolism. Catalytic subunit of the vitamin K epoxide reductase (VKOR)
complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K
0.778
IL8 ENSP00000306512, Homo sapiens interleukin 8; IL-8 is a chemotactic factor that attracts neutrophils, basophils,
and T-cells, but not monocytes. It is also involved in neutrophil activation. It is
released from several cell types in response to an inflammatory stimulus.
IL-8(6–77) has a 5–10-fold higher activity on neutrophil activation,
IL-8(5–77) has increased activity on neutrophil activation and IL-8(7–77)
has a higher affinity to receptors CXCR1 and CXCR2 as compared
to IL-8(1–77), respectively
0.764
TJP1 ENSP00000281537, Homo sapiens tight junction protein 1 (zona occludens 1); The N-terminal may be involved
in transducing a signal required for tight junction assembly, while the
C-terminal may have specific properties of tight junctions. The alpha
domain might be involved in stabilizing junctions
0.750
KCNN4 ENSP00000262888, Homo sapiens potassium intermediate/small conductance calcium-activated channel,
subfamily N, member 4; Forms a voltage-independent potassium channel
that is activated by intracellular calcium. Activation is followed by
membrane hyperpolarization which promotes calcium influx. The channel is
blocked by clotrimazole and charybdotoxin but is insensitive to apamin
0.748
doi:10.1371/journal.pone.0040173.t003
Calumenin and G551D - CFTR Association
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e40173a medium rate. Biacore sensorgrams were analyzed using the
BIAevaluation software. For each sample the obtained RU value
was the value on the active flow cell (FC) minus the value of the
reference FC, 20 seconds after the beginning of the dissociation
phase. Binding of pure calumenin was performed according to
Biacore’s recommendations on the CM5 sensor chips using an
Amine Coupling Kit (GE Healthcare) to achieve about 2000 RU
on FC2 and FC4, respectively. The surfaces were then blocked
with 1 M ethanolamine hydrochloride (pH 8.5). The reference
channels (FC1) were activated with equal volumes of NHS and
EDC and immediately saturated with ethanolamine. Binding
experiments were carried out at a flow rate of 5 ml/min using
HBS-EP buffer pH 7.4 as running buffer, in triplicate, at 25uC. In
between injections, the surface was regenerated by a 2 microliters
pulse of 50 mM NaOH, which was found to be a suitable
condition for removing the bound analyte on the immobilized
antibody with a very low impairment of the ligands. The results
presented here are from FC2-FC1. The reverse experiment in
which CFTR was bound was also performed (not shown). Bovine
Serum Albumin was used as a negative control. Affinity constants
were calculated using the Biacore 3000 Control Software’s wizard
(GE Healthcare).
STRING Query of Protein Interaction Network
The calumenin - CFTR interaction which was identified
experimentally was evaluated with the online Search Tool for
the Retrieval of Interacting Genes/Protein (STRING 9.0, http://
string-db.org) to predict both direct and indirect interactions [38].
The confident scoring of the interaction was based on known and
predicted protein interactions collected from direct (physical) and
indirect (functional) associations. The score was set at 0,4 which
represents a medium confidence. The database quantitatively
integrated interaction data from four sources - genomic context,
high-throughput experiments, co-expression and previous knowl-
edge from research publications. The results are presented with
the input protein (calumenin) in the context of a graphical network
of interaction partners. Associations in STRING are provided with
a probabilistic confidence score which represents an estimate of
how likely a given association describes a functional linkage
between two proteins. The score is computed and indicates higher
confidence when more than one type of information supports the
association (direct physical interactions, genetic interaction, text
mining, and experiments).
Statistics
Results are expressed as means 6 SEM for n cells. To compare
data, Student t tests were performed. P,0.01 was considered
statistically significant.
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